A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

Novo Nordisk's high dose Wegovy (semaglutide) has shown improved weight loss while remaining safe and tolerable. In the Phase ...

Veru said on Monday its experimental drug, in combination with Novo Nordisk's weight-loss treatment Wegovy, helped preserve muscle in older patients with obesity, meeting the main goal of a mid-stage ...

A recent review in Cureus outlines surgical cosmetic procedures after weight loss, educating clinicians in counseling patients on cosmetic and functional goals.

The Danish pharma giant posted impressive data for amycretin one month after the disappointing readout of CagriSema.

"What we're seeing for the first time is that curve is ... decline in obesity. Semaglutide, which belong to a class of drugs known as GLP-1 agonists, is the active ingredient found in the popular ...

Problematic obesity was ... The spread of these weight-loss drugs, produced by Novo Nordisk and Eli Lilly. Novo's drug is semaglutide, known as Ozempic for diabetics and Wegovy for weight loss ...

The skyrocketing popularity of weight-loss drugs like Wegovy, one of a class of drugs called GLP-1s, is fast becoming a state ...

Colorado plans to start limiting insurance coverage of prescription weight-loss drugs for its roughly 40,000 state employees, a cost-cutting measure in a difficult budget year that officials say will ...